BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Criterion Edge - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://criterionedge.com
X-WR-CALDESC:Events for Criterion Edge
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240605T120000
DTEND;TZID=America/Chicago:20240605T130000
DTSTAMP:20240815T202717Z
CREATED:20240522T170848Z
LAST-MODIFIED:20240815T202717Z
UID:5175-1717588800-1717592400@criterionedge.com
SUMMARY:Understanding FDA: Essentials for Briefing Books in Pre-IND\, Pre-NDA\, and Pre-BLA Meetings
DESCRIPTION:Join Criterion Edge on June 5th\, 2024\, at 12 PM CST for an enlightening session with Geoff Fatzinger\, our Senior Regulatory Consultant. Dive deep into the essentials of FDA interactions in our webinar: “Understanding FDA: Essentials for Briefing Books in Pre-IND\, Pre-NDA\, and Pre-BLA Meetings.” Uncover the intricacies of FDA expectations and learn how to craft effective briefing books tailored for success in pre-IND\, pre-NDA\, and pre-BLA meetings. From interpreting FDA requirements to tailoring your submissions\, this webinar is your gateway to mastering FDA regulatory engagements. \nLearning Objectives: \nInterpreting FDA Expectations:\n● Develop a clear understanding of the FDA’s expectations during pre-IND\, pre-NDA\, and pre-BLA interactions.\n● Navigate the nuances of FDA requirements for compliance. \nBuilding Effective Briefing Books:\n● Identify and comprehend the key components integral to crafting briefing books.\n● Learn best practices for organizing information to facilitate communication with the FDA. \nTailoring Briefing Books for FDA Meetings:\n● Explore considerations when tailoring briefing books to align with the FDA’s unique review processes.\n● Understand how to address FDA preferences and requirements for optimized submissions. \nAchieving Success in FDA Interactions:\n● Overcome common challenges encountered in FDA meetings and briefing book preparation.\n● Gain insights into practical strategies for navigating the FDA regulatory landscape. \nJoin us for this informative webinar on FDA interactions\, where our expert will share valuable insights to enhance your briefing book preparation for successful engagements with the FDA. \nWATCH NOW
URL:https://criterionedge.com/event/understanding-fda-essentials-for-briefing-books-in-pre-ind-pre-nda-and-pre-bla-meetings/
LOCATION:Webinar\, United States
ATTACH;FMTTYPE=image/png:https://criterionedge.com/wp-content/uploads/June-5-2024.png
ORGANIZER;CN="Criterion Edge":MAILTO:support@criterionedge.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240625T130000
DTEND;TZID=America/Chicago:20240625T140000
DTSTAMP:20240815T202621Z
CREATED:20240606T151732Z
LAST-MODIFIED:20240815T202621Z
UID:5546-1719320400-1719324000@criterionedge.com
SUMMARY:Considerations for Companion Diagnostics: Lessons Learned and Key Takeaways from DIA 2024
DESCRIPTION:The In Vitro Diagnostics Regulation (IVDR) took effect in May 2022 and has introduced substantial changes in the regulatory framework for in vitro diagnostic medical devices (IVDs) in Europe. IVD manufacturers are expected to meet more rigorous standards for clinical evidence\, with up to 80% of IVDs requiring Notified Body certificates under IVDR. \nDr. Sarah Chavez\, Criterion Edge Director of IVD Writing Services\, will discuss key insider insights gleaned from the 2024 DIA meeting to share and discuss the key take-aways from the Symposium\, including clinical evidence requirements and strategies to keep your report writing and data collection on track. \nJoin us for this webinar to discuss differences in EU and US regulations for IVD clinical performance studies and potential implications for companion diagnostic developers. The goals of this webinar are to: \n\nUnderstand how new regulatory requirements apply to CDx and what are potential implications from both the IVD and Pharma partners’ perspectives.\nDevelop a strategic approach to ensure compliance with IVDR requirements for CDx\, covering essential aspects such as quality management\, documentation\, and early interactions with your notified body.\nAddress common challenges faced during the implementation of IVDR requirements for CDx\, exploring potential solutions and proactive measures to streamline the regulatory compliance process.\n\nWATCH NOW
URL:https://criterionedge.com/event/considerations-for-companion-diagnostics-lessons-learned-and-key-takeaways-from-dia-2024/
LOCATION:Webinar\, United States
CATEGORIES:IVDR Webinars
ATTACH;FMTTYPE=image/png:https://criterionedge.com/wp-content/uploads/June-25-2024.png
ORGANIZER;CN="Criterion Edge":MAILTO:support@criterionedge.com
END:VEVENT
END:VCALENDAR